Jazz Pharmaceuticals
Clinical trials sponsored by Jazz Pharmaceuticals, explained in plain language.
-
CBD study for infant seizures halted early
Symptom relief TerminatedThis study tested a cannabidiol (CBD) oral solution in children under 2 years old with tuberous sclerosis complex, Dravet syndrome, or Lennox-Gastaut syndrome whose seizures were not well-controlled. The main goals were to check safety and how the body processes the drug. Only 3 …
Phase: PHASE3 • Sponsor: Jazz Pharmaceuticals • Aim: Symptom relief
Last updated May 11, 2026 20:48 UTC
-
New narcolepsy drug shows promise in early trial
Symptom relief TerminatedThis early-stage study tested a new drug called JZP441 in 6 adults with narcolepsy type 1, a condition that causes sudden sleep attacks. The goal was to see if the drug helps people stay awake during the day and to check for side effects. The study was stopped early, but results …
Phase: PHASE1 • Sponsor: Jazz Pharmaceuticals • Aim: Symptom relief
Last updated May 06, 2026 16:01 UTC